<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="retraction"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Medicine (Baltimore)</journal-id><journal-id journal-id-type="iso-abbrev">Medicine (Baltimore)</journal-id><journal-id journal-id-type="publisher-id">MEDI</journal-id><journal-title-group><journal-title>Medicine</journal-title></journal-title-group><issn pub-type="ppub">0025-7974</issn><issn pub-type="epub">1536-5964</issn><publisher><publisher-name>Wolters Kluwer Health</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">28816990</article-id><article-id pub-id-type="pmc">5571727</article-id><article-id pub-id-type="publisher-id">MD-D-17-04837</article-id><article-id pub-id-type="doi">10.1097/MD.0000000000007871</article-id><article-id pub-id-type="art-access-id">07871</article-id><article-categories><subj-group subj-group-type="heading"><subject>Retraction</subject></subj-group></article-categories><title-group><article-title>A randomized controlled trial of botulinum toxin A for treating
neuropathic pain in patients with spinal cord injury: Retraction</article-title></title-group><pub-date pub-type="collection"><month>8</month><year>2017</year></pub-date><pub-date pub-type="epub"><day>18</day><month>8</month><year>2017</year></pub-date><volume>96</volume><issue>33</issue><elocation-id>e7871</elocation-id><permissions><copyright-statement>Copyright &#x000a9; 2017 the Author(s). Published by Wolters Kluwer
Health, Inc.</copyright-statement><copyright-year>2017</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0"><license-p>This is an open access article distributed under the Creative Commons Attribution
License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction
in any medium, provided the original work is properly cited. <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0">http://creativecommons.org/licenses/by/4.0</ext-link></license-p></license></permissions><self-uri xlink:type="simple" xlink:href="medi-96-e7871.pdf"/><related-article id="d35e56" related-article-type="retracted-article" ext-link-type="doi" xlink:href="10.1097/MD.0000000000006919" vol="96" page="e6919"/><custom-meta-group><custom-meta><meta-name>OPEN-ACCESS</meta-name><meta-value>TRUE</meta-value></custom-meta></custom-meta-group></article-meta></front><body><p>The article, &#x0201c;A randomized controlled trial of botulinum toxin A for treating
neuropathic pain in patients with spinal cord injury&#x0201d;,<sup>[<xref rid="R1" ref-type="bibr">1</xref>]</sup> which appeared in Volume 96, Issue 20 of
<italic>Medicine</italic>, has been retracted for plagiarism and academic fraud. Similar
design study, language, and tables were found in a previously published article,
&#x0201c;Botulinum toxin type A for neuropathic pain in patients with spinal cord
injury&#x0201d;,<sup>[<xref rid="R2" ref-type="bibr">2</xref>]</sup> which appeared in
Volume 79, Issue 4 of <italic>Annals of Neurology</italic>, without any attribution or
citation.</p></body><back><ref-list><title>References</title><ref id="R1"><label>[1]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>G</given-names></name><name><surname>Lv</surname><given-names>C</given-names></name><name><surname>Tian</surname><given-names>L</given-names></name></person-group>
<article-title>A randomized controlled trial of botulinum toxin A
for treating neuropathic pain in patients with spinal cord injury</article-title>.
<source><italic>Medicine</italic></source>. <year>2017</year>
<volume>96</volume>:<fpage>e6919</fpage>.<pub-id pub-id-type="pmid">28514309</pub-id></mixed-citation></ref><ref id="R2"><label>[2]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Han</surname><given-names>Z</given-names></name><name><surname>Song</surname><given-names>D-H</given-names></name><name><surname>O</surname><given-names>H-M</given-names></name></person-group>
<article-title>Botulinum toxin type A for neuropathic pain in
patients with spinal cord injury</article-title>. <source><italic>Annals of
Neurology</italic></source>.
<volume>79</volume>;<issue>4</issue>:<fpage>569</fpage>&#x02013;<lpage>578</lpage>.<pub-id pub-id-type="pmid">26814620</pub-id></mixed-citation></ref></ref-list></back></article>